Tim Anderson

Tim Anderson is a Partner, Head of Research and a co-founding member of Cowen Healthcare Investments. He focuses on investments in life science and digital medicine companies that have the potential to meaningfully address serious medical conditions. Mr. Anderson is currently a member of the Board of Directors of F2G, Autobahn Therapeutics, Cadent Therapeutics, Cullinan Oncology and VectivBio. Mr. Anderson previously served as a Board Member or Observer of Therachon, Precision Biosciences, and Livongo Health.

Prior to his role at Cowen Healthcare Investments, Mr. Anderson was a biotechnology investment banker on Cowen’s healthcare investment banking team. Mr. Anderson holds a BA in economics from Bowdoin College.